$SEEL
Seelos Therapeutics Inc Stock $seel

$seel Overview Financials Valuation SEC Filings Company Website

2013 Q1 Form 10-Q Financial Statement

#000119312513213296 Filed on May 10, 2013

Income Statement

Concept	2013 Q1	2012 Q1
Revenue	$929.0K	$669.0K
YoY Change	38.86%	-57.84%
Cost Of Revenue	$1.847M	$76.00K
YoY Change	2330.26%	-91.67%
Gross Profit	-$922.0K	$669.0K
YoY Change	-237.82%	14.95%
Gross Profit Margin	-99.25%	100.0%
Selling, General & Admin	$3.830M	$3.993M
YoY Change	-4.08%	37.39%
% of Gross Profit		596.84%
Research & Development	$1.413M	$1.177M
YoY Change	20.05%	6.95%
% of Gross Profit		175.93%
Depreciation & Amortization	$21.00K	$98.00K
YoY Change	-78.57%	-60.06%
% of Gross Profit		14.65%
Operating Expenses	$5.239M	$4.417M
YoY Change	18.61%	10.24%
Operating Profit	-$6.161M	-$3.712M
YoY Change	65.98%	8.39%
Interest Expense	-$231.0K	$173.5K
YoY Change	-233.14%	56.47%
% of Operating Profit
Other Income/Expense, Net	-$789.0K	$45.00K
YoY Change	-1853.33%	227.61%
Pretax Income	-$6.950M	-$3.700M
YoY Change	87.84%	8.5%
Income Tax
% Of Pretax Income
Net Earnings	-$8.673M	-$4.713M
YoY Change	84.02%	38.17%
Net Earnings / Revenue	-933.58%	-704.48%
Basic Earnings Per Share
Diluted Earnings Per Share	-$78.82M	-$58.88M
COMMON SHARES
Basic Shares Outstanding	30.34M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2013 Q1	2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$14.10M	$21.53M
YoY Change	-34.51%	111.49%
Cash & Equivalents	$14.10M	$21.53M
Short-Term Investments
Other Short-Term Assets	$980.0K	$400.0K
YoY Change	145.0%	-20.0%
Inventory		$303.1K
Prepaid Expenses
Receivables	$499.0K	$891.9K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$15.58M	$23.13M
YoY Change	-32.62%	102.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$615.0K	$4.316M
YoY Change	-85.75%	-17.8%
Goodwill		$1.130M
YoY Change
Intangibles		$2.844M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$98.00K	$460.4K
YoY Change	-78.71%	58.75%
Total Long-Term Assets	$1.045M	$8.750M
YoY Change	-88.06%	6.97%
TOTAL ASSETS
Total Short-Term Assets	$15.58M	$23.13M
Total Long-Term Assets	$1.045M	$8.750M
Total Assets	$16.63M	$31.88M
YoY Change	-47.84%	62.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.850M	$740.0K
YoY Change	150.0%	-47.52%
Accrued Expenses	$3.734M	$2.462M
YoY Change	51.65%	262.09%
Deferred Revenue
YoY Change
Short-Term Debt	$1.410M	$4.000M
YoY Change	-64.75%	1718.18%
Long-Term Debt Due		$0.00
YoY Change		-100.0%
Total Short-Term Liabilities	$10.17M	$9.893M
YoY Change	2.79%	289.49%
LONG-TERM LIABILITIES
Long-Term Debt	$3.390M	$20.00K
YoY Change	16850.0%	-99.51%
Other Long-Term Liabilities	$218.0K	$97.83K
YoY Change	122.84%	-88.62%
Total Long-Term Liabilities	$218.0K	$97.83K
YoY Change	122.84%	-98.03%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.17M	$9.893M
Total Long-Term Liabilities	$218.0K	$97.83K
Total Liabilities	$17.24M	$11.70M
YoY Change	47.3%	56.23%
SHAREHOLDERS EQUITY
Retained Earnings	-$259.8M	-$224.1M
YoY Change	15.95%
Common Stock	$258.5M	$244.2M
YoY Change	5.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$609.0K	$20.17M
YoY Change
Total Liabilities & Shareholders Equity	$16.63M	$31.88M
YoY Change	-47.84%	62.64%

Cashflow Statement

Concept	2013 Q1	2012 Q1
OPERATING ACTIVITIES
Net Income	-$8.673M	-$4.713M
YoY Change	84.02%	38.17%
Depreciation, Depletion And Amortization	$21.00K	$98.00K
YoY Change	-78.57%	-60.06%
Cash From Operating Activities	-$6.770M	-$5.159M
YoY Change	31.22%	112.03%
INVESTING ACTIVITIES
Capital Expenditures	$37.00K	$20.00K
YoY Change	85.0%	151.64%
Acquisitions
YoY Change
Other Investing Activities	$4.870M	-$260.0K
YoY Change	-1973.08%
Cash From Investing Activities	$4.830M	-$280.0K
YoY Change	-1824.81%	3423.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$791.0K	$19.49M
YoY Change	-95.94%	699.76%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	790.0K	19.53M
YoY Change	-95.96%	462.82%
NET CHANGE
Cash From Operating Activities	-6.770M	-5.159M
Cash From Investing Activities	4.830M	-280.0K
Cash From Financing Activities	790.0K	19.53M
Net Change In Cash	-1.150M	14.09M
YoY Change	-108.16%	1269.16%
FREE CASH FLOW
Cash From Operating Activities	-$6.770M	-$5.159M
Capital Expenditures	$37.00K	$20.00K
Free Cash Flow	-$6.807M	-$5.179M
YoY Change	31.42%	112.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	602000
CY2013Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	733000
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1900000	shares
CY2013Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3900000
CY2012Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3205492	shares
CY2012Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	4.56
CY2012Q1	apri	Class Of Warrant Or Rights Weighted Average Remaining Contractual Term ClassOfWarrantOrRightsWeightedAverageRemainingContractualTerm	P3Y9M18D
CY2012Q1	apri	Class Of Warrant Term ClassOfWarrantTerm	P5Y
CY2012Q1	apri	Warrants Risk Free Interest Rate WarrantsRiskFreeInterestRate	0.010	pure
CY2012Q1	apri	Warrants Expected Volatility WarrantsExpectedVolatility	0.700	pure
CY2012Q1	apri	Warrants Aggregate Grant Date Fair Value WarrantsAggregateGrantDateFairValue	3700000
CY2012Q3	apri	Percentage Of Ownership Interests Acquired PercentageOfOwnershipInterestsAcquired	1.00	pure
CY2012Q4	us-gaap	Long Lived Assets Held For Sale Impairment Charge LongLivedAssetsHeldForSaleImpairmentCharge	500000
CY2012Q4	apri	Contractual Sales Price For Divestiture Of Business ContractualSalesPriceForDivestitureOfBusiness	4100000
CY2012Q4	apri	Long Lived Assets Held For Sale Estimated Selling Cost LongLivedAssetsHeldForSaleEstimatedSellingCost	500000
CY2013Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	30542445	shares
CY2012Q3	apri	Percentage Of Ownership Interests Acquired PercentageOfOwnershipInterestsAcquired	1.00	pure
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21529000
CY2013Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	202000
CY2013Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	116000
CY2013Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	258443000
CY2013Q1	us-gaap	Escrow Deposit EscrowDeposit	200000
CY2013Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	98000
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	626277	shares
CY2013Q1	us-gaap	Stockholders Equity StockholdersEquity	-609000
CY2013Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	35000
CY2013Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	35000
CY2013Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	4000000
CY2013Q1	us-gaap	Shares Issued SharesIssued	38873	shares
CY2013Q1	us-gaap	Business Acquisition Contingent Consideration At Fair Value Current BusinessAcquisitionContingentConsiderationAtFairValueCurrent	1407000
CY2013Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	41000
CY2013Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2013Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	226000
CY2013Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	720000
CY2013Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1491000
CY2013Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	10584
CY2013Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	499000
CY2013Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16628000
CY2013Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	119000
CY2013Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	332000
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	392547
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14104000
CY2013Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30354715	shares
CY2013Q1	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	425000
CY2013Q1	us-gaap	Deferred Compensation Arrangement With Individual Recorded Liability DeferredCompensationArrangementWithIndividualRecordedLiability	1900000
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2682872	shares
CY2013Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2013Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	343000
CY2013Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	506000
CY2013Q1	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	142000
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.67
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	392547
CY2013Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30354715	shares
CY2013Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	731000
CY2013Q1	us-gaap	Liabilities Liabilities	17237000
CY2013Q1	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	76000
CY2013Q1	us-gaap	Disposal Group Including Discontinued Operation Other Current Liabilities DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities	116000
CY2013Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	504000
CY2013Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	218000
CY2013Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2013Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	296000
CY2013Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-259801000
CY2013Q1	us-gaap	Disposal Group Including Discontinued Operation Other Current Assets DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets	35000
CY2013Q1	us-gaap	Assets Assets	16628000
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.24
CY2013Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	3394000
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	719000
CY2013Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	4800000	shares
CY2013Q1	us-gaap	Business Acquisition Contingent Consideration At Fair Value Noncurrent BusinessAcquisitionContingentConsiderationAtFairValueNoncurrent	443000
CY2013Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3734000
CY2013Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	129000
CY2013Q1	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	1522000
CY2013Q1	us-gaap	Liabilities Current LiabilitiesCurrent	10169000
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2756187	shares
CY2013Q1	us-gaap	Common Stock Value CommonStockValue	30000
CY2013Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	3394000
CY2013Q1	us-gaap	Assets Current AssetsCurrent	15583000
CY2013Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent
CY2013Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1850000
CY2013Q1	us-gaap	Preferred Stock Value PreferredStockValue
CY2013Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	118000
CY2013Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	615000
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	3.24
CY2013Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	116000
CY2013Q1	apri	Accrued Compensation Current AccruedCompensationCurrent	1931000
CY2013Q1	apri	Assets Of Disposal Group Including Discontinued Operation Current Assets AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAssets	35000
CY2013Q1	apri	Disposal Group Including Discontinued Operation Deferred Revenue DisposalGroupIncludingDiscontinuedOperationDeferredRevenue	116000
CY2013Q1	apri	Research And Development Accrued Expense ResearchAndDevelopmentAccruedExpense	1265000
CY2013Q1	apri	Accrued Consulting Fees Current AccruedConsultingFeesCurrent	722000
CY2002Q4	us-gaap	Deferred Compensation Arrangement With Individual Recorded Liability DeferredCompensationArrangementWithIndividualRecordedLiability	1000000
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7435000
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	590000
CY2012Q4	us-gaap	Assets Held For Sale Current AssetsHeldForSaleCurrent	3654000
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	698000
CY2012Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	4000000
CY2012Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	57000
CY2012Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	3527000
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	257078000
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	100000
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	6621000
CY2012Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	791000
CY2012Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	2731000
CY2012Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	4000000
CY2012Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	126000
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2012Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	318000
CY2012Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	244000
CY2012Q4	us-gaap	Disposal Group Including Discontinued Operation Inventory DisposalGroupIncludingDiscontinuedOperationInventory	285000
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	52000
CY2012Q4	us-gaap	Disposal Group Including Discontinued Operation Intangible Assets Net DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNet	1877000
CY2012Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	587000
CY2012Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	17000
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29937669	shares
CY2012Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	286000
CY2012Q4	us-gaap	Liabilities Liabilities	17258000
CY2012Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	76000
CY2012Q4	us-gaap	Disposal Group Including Discontinued Operation Other Current Liabilities DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities	3527000
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	536000
CY2012Q4	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment Net DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNet	40000
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y10M24D
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	196000
CY2012Q4	us-gaap	Disposal Group Including Discontinued Operation Other Noncurrent Assets DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets	23000
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2012Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	359000
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-251128000
CY2012Q4	us-gaap	Disposal Group Including Discontinued Operation Other Current Assets DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets	506000
CY2012Q4	us-gaap	Assets Assets	23879000
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.71
CY2012Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	3413000
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	678000
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23879000
CY2012Q4	us-gaap	Disposal Group Including Discontinued Operation Accrued Liabilities DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities	1087000
CY2012Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	130000
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	343000
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15130000
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29937669	shares
CY2012Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	616000
CY2012Q4	us-gaap	Deferred Compensation Arrangement With Individual Recorded Liability DeferredCompensationArrangementWithIndividualRecordedLiability	2100000
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	641000
CY2012Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	448000
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1841000
CY2012Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	31000
CY2012Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	1529000
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10766000
CY2012Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Noncurrent AssetsOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	1940000
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2213916	shares
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	30000
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	3413000
CY2012Q4	us-gaap	Assets Current AssetsCurrent	20895000
CY2012Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	906000
CY2012Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable DisposalGroupIncludingDiscontinuedOperationAccountsPayable	699000
CY2012Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent
CY2012Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	2284000
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	97000
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	601000
CY2012Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	3975000
CY2012Q4	apri	Accrued Compensation Current AccruedCompensationCurrent	1905000
CY2012Q4	apri	Disposal Group Including Discontinued Operation Product Warranty Accrual Classified Current DisposalGroupIncludingDiscontinuedOperationProductWarrantyAccrualClassifiedCurrent	170000
CY2012Q4	apri	Assets Of Disposal Group Including Discontinued Operation Current Assets AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAssets	791000
CY2012Q4	apri	Disposal Group Including Discontinued Operation Deferred Revenue DisposalGroupIncludingDiscontinuedOperationDeferredRevenue	243000
CY2012Q4	apri	Research And Development Accrued Expense ResearchAndDevelopmentAccruedExpense	564000
CY2012Q4	apri	Disposal Group Including Discontinued Operation Contingent Consideration Current DisposalGroupIncludingDiscontinuedOperationContingentConsiderationCurrent	1328000
CY2012Q4	apri	Disposal Group Including Discontinued Operation Contingent Consideration Noncurrent DisposalGroupIncludingDiscontinuedOperationContingentConsiderationNoncurrent	420000
CY2012Q4	apri	Accrued Consulting Fees Current AccruedConsultingFeesCurrent	388000
CY2012Q4	apri	Disposal Group Including Discontinued Operation Product Warranty Accrual Classified Non Current DisposalGroupIncludingDiscontinuedOperationProductWarrantyAccrualClassifiedNonCurrent	28000
CY2013Q1	dei	Trading Symbol TradingSymbol	APRI
CY2013Q1	dei	Amendment Flag AmendmentFlag	false
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-6158000
CY2013Q1	dei	Entity Registrant Name EntityRegistrantName	APRICUS BIOSCIENCES, INC.
CY2013Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2013Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2013Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013Q1	dei	Document Period End Date DocumentPeriodEndDate	2013-03-31
CY2013Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001017491
CY2013Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2013Q1	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	739000
CY2013Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-3000
CY2013Q1	dei	Document Type DocumentType	10-Q
CY2013Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-6947000
CY2013Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	441000
CY2013Q1	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	1500000
CY2013Q1	us-gaap	Contracts Revenue ContractsRevenue	882000
CY2013Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-631000
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8595000
CY2013Q1	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-761000
CY2013Q1	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	38873	shares
CY2013Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P9Y2M12D
CY2013Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	21000
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	441000
CY2013Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.44
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-6011000
CY2013Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	4000
CY2013Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	105000
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-416000
CY2013Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	791000
CY2013Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y2M12D
CY2013Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-648000
CY2013Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.58
CY2013Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	291000
CY2013Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3657000
CY2013Q1	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	100000
CY2013Q1	us-gaap	Operating Expenses OperatingExpenses	5259000
CY2013Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-231000
CY2013Q1	us-gaap	Cost Of Services CostOfServices	1847000
CY2013Q1	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.23
CY2013Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.29
CY2013Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	37000
CY2013Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1026000
CY2013Q1	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	38000
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3846000
CY2013Q1	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	157000
CY2013Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	3600000
CY2013Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.06
CY2013Q1	us-gaap	Accretion Expense Including Asset Retirement Obligations AccretionExpenseIncludingAssetRetirementObligations	68000
CY2013Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-32000
CY2013Q1	us-gaap	Accretion Expense AccretionExpense	90000
CY2013Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1726000
CY2013Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	133000
CY2013Q1	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	416000
CY2013Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	Segment
CY2013Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	791000
CY2013Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1413000
CY2013Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	113000
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	541500	shares
CY2013Q1	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	90000
CY2013Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	25000
CY2013Q1	us-gaap	Sales Revenue Net SalesRevenueNet	1019000
CY2013Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-164000
CY2013Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	78000
CY2013Q1	us-gaap	Licenses Revenue LicensesRevenue	32000
CY2013Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y2M12D
CY2013Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	71000
CY2013Q1	us-gaap	Depreciation Depreciation	20000
CY2013Q1	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-285000
CY2013Q1	us-gaap	Gross Profit GrossProfit	-899000
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	791000
CY2013Q1	us-gaap	Proceeds From Sale Of Buildings ProceedsFromSaleOfBuildings	4100000
CY2013Q1	us-gaap	Interest Paid InterestPaid	73000
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	3329000
CY2013Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	30178265	shares
CY2013Q1	us-gaap	Debtor Reorganization Items Write Off Of Deferred Financing Costs And Debt Discounts DebtorReorganizationItemsWriteOffOfDeferredFinancingCostsAndDebtDiscounts	10000
CY2013Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	100000
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-8673000
CY2013Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-789000
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1083771	shares
CY2013Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	126000
CY2013Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	173000
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.54
CY2013Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	30000
CY2013Q1	apri	Gain Loss On Sale Of Assets GainLossOnSaleOfAssets	-1429000
CY2012Q1	us-gaap	Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax	-3667000
CY2012Q1	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	-924000
CY2012Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	51000
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3712000
CY2012Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	110000
CY2012Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-512000
CY2012Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	19489000
CY2012Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5000
CY2012Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3667000
CY2012Q1	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-260000
CY2012Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4713000
CY2012Q1	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-664000
CY2012Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	98000
CY2012Q1	us-gaap	Share Based Compensation ShareBasedCompensation	535000
CY2012Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	781000
CY2012Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-4496000
CY2012Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.20
CY2012Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	10000
CY2012Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.05
CY2012Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	177000
CY2012Q1	us-gaap	Accretion Expense AccretionExpense	99000
CY2012Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1046000
CY2012Q1	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	1046000
CY2012Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20000
CY2012Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	14094000
CY2012Q1	us-gaap	Weighted Average Basic Shares Outstanding Pro Forma WeightedAverageBasicSharesOutstandingProForma	24013386	shares
CY2012Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3240000
CY2012Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	90000
CY2012Q1	us-gaap	Sales Revenue Net SalesRevenueNet	781000
CY2012Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	871000
CY2012Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	35000
CY2012Q1	us-gaap	Licenses Revenue LicensesRevenue	671000
CY2012Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1177000
CY2012Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-286000
CY2012Q1	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	111000
CY2012Q1	us-gaap	Operating Expenses OperatingExpenses	4417000
CY2012Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-71000
CY2012Q1	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.15
CY2012Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	76000
CY2012Q1	us-gaap	Depreciation Depreciation	100000
CY2012Q1	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-43000
CY2012Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	42000
CY2012Q1	us-gaap	Gross Profit GrossProfit	705000
CY2012Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	19534000
CY2012Q1	us-gaap	Interest Paid InterestPaid	74000
CY2012Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-20000
CY2012Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	24013386	shares
CY2012Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	100000
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	-4713000
CY2012Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	45000
CY2012Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	55000
CY2012Q1	apri	Business Acquisitions Pro Forma Income Loss From Discontinued Operations Net Of Tax BusinessAcquisitionsProFormaIncomeLossFromDiscontinuedOperationsNetOfTax	-1046000
CY2012Q1	apri	Business Acquisition Pro Forma Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share BusinessAcquisitionProFormaIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.05
CY2012Q1	apri	Business Acquisition Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax Per Share Basic And Diluted BusinessAcquisitionProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTaxPerShareBasicAndDiluted	-0.15

Files In Submission

Name	View Source	Status
0001193125-13-213296-index-headers.html	Edgar Link	pending
0001193125-13-213296-index.html	Edgar Link	pending
0001193125-13-213296.txt	Edgar Link	pending
0001193125-13-213296-xbrl.zip	Edgar Link	pending
apri-20130331.xml	Edgar Link	completed
apri-20130331.xsd	Edgar Link	pending
apri-20130331_cal.xml	Edgar Link	unprocessable
apri-20130331_def.xml	Edgar Link	unprocessable
apri-20130331_lab.xml	Edgar Link	unprocessable
apri-20130331_pre.xml	Edgar Link	unprocessable
d500624d10q.htm	Edgar Link	pending
d500624dex11.htm	Edgar Link	pending
d500624dex311.htm	Edgar Link	pending
d500624dex312.htm	Edgar Link	pending
d500624dex321.htm	Edgar Link	pending
d500624dex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SEEL
Seelos Therapeutics Inc Stock $seel

2013 Q1 Form 10-Q Financial Statement

#000119312513213296 Filed on May 10, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SEEL Seelos Therapeutics Inc Stock $seel

2013 Q1 Form 10-Q Financial Statement

#000119312513213296 Filed on May 10, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SEEL
Seelos Therapeutics Inc Stock $seel